Skip to nav Skip to content

HIV and COVID-19 – What We’ve Learned

Facebook Twitter LinkedIn Email

How has our knowledge of COVID-19 and how it affects people with HIV evolved? IDSA board member Max Brito, MD, FIDSA of the University of Illinois at Chicago and HIVMA board member Rachel Bender Ignacio, MD, FIDSA of the University of Washington discuss the latest COVID-19 clinical considerations for people with HIV and the broader impacts of the COVID-19 pandemic on the HIV community and efforts to end the HIV epidemic.

**This podcast episode was funded by a cooperative agreement with the Centers for Disease Control and Prevention (grant number NU50CK000574). The Centers for Disease Control and Prevention is an agency within the Department of Health and Human Services (HHS). The contents of this podcast do not necessarily represent the policy of CDC or HHS, and should not be considered an endorsement by the Federal Government.




This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.